Richard Eisenberg of Forbes writes about a symposium hosted by the MIT AgeLab, which explored the impact of Alzheimer’s and dementia on financial planning. The symposium “brought together a broad spectrum of experts ranging from Alzheimer’s Association execs to neurology professors to financial advisers to people who have early onset Alzheimer’s or are married to them,” writes Eisenberg.
Dr. Joseph Coughlin, director of the MIT Age Lab, collaborated on a study that indicates that grandchildren are likely to take financial advice from their grandparents, writes Kimberly Palmer of U.S. News & World Report. “Grandparents can tell stories and explain how they were able to muddle through or succeed,” says Coughlin.
Lisa Kiplinger writes for USA Today about research from Dr. Joseph Coughlin, director of the the MIT AgeLab, that indicates that 85 percent of Millennials are open to having conversations about finances with their grandparents, but only 8 percent of grandparents are likely to initiate the conversation.
Wall Street Journal reporter Ed Silverman interviews Professor Andrew Lo about his proposal that a public-private partnership could solve funding issues for drugs research and development. “Right now, the risk of failure [in developing an Alzheimer’s treatment] is far too high for any single pharmaceutical company to take on,” Lo explains.
“Based on the current rates of success in creating new drugs for Alzheimer's disease, it could take 260 years until the next one is approved,” writes The Boston Globe’s Carolyn Johnson on the rationale for why Professor Andrew Lo is proposing a new, portfolio-based approach to Alzheimer's research.
NPR’s Jim Zarroli reports on new MIT research that explores how tax evasion techniques like round-tripping can hurt the U.S. economy.